Carlisle, Annette
Lieberman, Jay Adam
Article History
Accepted: 26 August 2024
First Online: 19 September 2024
Declarations
:
: Dr. Carlisle has no competing interests. Dr. Lieberman reports personal fees from ARS, personal fees from Aquestive, personal fees from Bryn, other from DBV, personal fees from ALK, personal fees from Siolta, personal fees from Abbvie, outside the submitted work; and Board of Directors for American Board of Allergy and Immunology. Member of the Joint Task Force for Practice Parameters (responsible for guideline development).
: This article does not contain any studies with human or animal subjects performed by any of the authors.